CBD and Marijuana

CBD and Marijuana Policy

As Congress continues its work, policymakers should draw on the expertise and experience of the alcohol industry and public health leaders when contemplating and addressing needed regulation, revenue and research principles in the marijuana industry. Additionally, since the enactment of the 2018 Farm Bill, there has been considerable confusion in the marketplace about the legality of products containing cannabidiol (CBD) and further federal guidance on this issue is needed. Congress should exercise its authority to provide greater clarity to stakeholders on federal oversight of the marijuana and CBD marketplace.

We Encourage Congress To:

  • Urge the Food and Drug Administration (FDA) to provide stakeholders further guidance on the regulatory pathway forward for CBD. Consider the established and effective regulatory policies of the alcohol industry as a guide when determining regulatory policies for the marijuana industry.